nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF1—dermis—psoriasis	0.0833	0.503	CbGeAlD
Pentosan Polysulfate—FGF1—skin epidermis—psoriasis	0.035	0.211	CbGeAlD
Pentosan Polysulfate—FGF1—endothelium—psoriasis	0.0254	0.153	CbGeAlD
Pentosan Polysulfate—FGF2—tendon—psoriasis	0.0111	0.067	CbGeAlD
Pentosan Polysulfate—FGF1—skin of body—psoriasis	0.0109	0.0655	CbGeAlD
Pentosan Polysulfate—Infection—Cyclosporine—psoriasis	0.000512	0.000934	CcSEcCtD
Pentosan Polysulfate—Malaise—Hydrocortisone—psoriasis	0.000506	0.000924	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Cyclosporine—psoriasis	0.000505	0.000921	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Mycophenolic acid—psoriasis	0.000504	0.000919	CcSEcCtD
Pentosan Polysulfate—Dizziness—Hydroxyurea—psoriasis	0.000503	0.000918	CcSEcCtD
Pentosan Polysulfate—Oedema—Mycophenolate mofetil—psoriasis	0.000503	0.000917	CcSEcCtD
Pentosan Polysulfate—Infection—Mycophenolate mofetil—psoriasis	0.0005	0.000911	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Cyclosporine—psoriasis	0.000499	0.000909	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000493	0.000898	CcSEcCtD
Pentosan Polysulfate—Anorexia—Cyclosporine—psoriasis	0.000492	0.000897	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Triamcinolone—psoriasis	0.000491	0.000895	CcSEcCtD
Pentosan Polysulfate—Alopecia—Dexamethasone—psoriasis	0.000487	0.000888	CcSEcCtD
Pentosan Polysulfate—Alopecia—Betamethasone—psoriasis	0.000487	0.000888	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Mycophenolate mofetil—psoriasis	0.000486	0.000887	CcSEcCtD
Pentosan Polysulfate—Vomiting—Hydroxyurea—psoriasis	0.000484	0.000883	CcSEcCtD
Pentosan Polysulfate—Discomfort—Prednisolone—psoriasis	0.000484	0.000882	CcSEcCtD
Pentosan Polysulfate—Abdominal discomfort—Methotrexate—psoriasis	0.000481	0.000876	CcSEcCtD
Pentosan Polysulfate—Rash—Hydroxyurea—psoriasis	0.00048	0.000875	CcSEcCtD
Pentosan Polysulfate—Anorexia—Mycophenolate mofetil—psoriasis	0.00048	0.000875	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Hydroxyurea—psoriasis	0.00048	0.000874	CcSEcCtD
Pentosan Polysulfate—Myalgia—Hydrocortisone—psoriasis	0.000478	0.000872	CcSEcCtD
Pentosan Polysulfate—Malaise—Triamcinolone—psoriasis	0.000477	0.00087	CcSEcCtD
Pentosan Polysulfate—Headache—Hydroxyurea—psoriasis	0.000477	0.00087	CcSEcCtD
Pentosan Polysulfate—Discomfort—Hydrocortisone—psoriasis	0.000472	0.000861	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.00047	0.000857	CcSEcCtD
Pentosan Polysulfate—Oedema—Prednisolone—psoriasis	0.000469	0.000856	CcSEcCtD
Pentosan Polysulfate—Insomnia—Cyclosporine—psoriasis	0.000466	0.000851	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Cyclosporine—psoriasis	0.000463	0.000845	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Cyclosporine—psoriasis	0.00046	0.000839	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000458	0.000836	CcSEcCtD
Pentosan Polysulfate—Oedema—Hydrocortisone—psoriasis	0.000458	0.000836	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Methotrexate—psoriasis	0.000458	0.000834	CcSEcCtD
Pentosan Polysulfate—Infection—Hydrocortisone—psoriasis	0.000455	0.00083	CcSEcCtD
Pentosan Polysulfate—Insomnia—Mycophenolate mofetil—psoriasis	0.000455	0.00083	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Cyclosporine—psoriasis	0.000454	0.000828	CcSEcCtD
Pentosan Polysulfate—FGF4—DAP12 interactions—IL6—psoriasis	0.000454	0.00159	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by FGFR in disease—IL6—psoriasis	0.000454	0.00159	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Fc epsilon receptor (FCERI) signaling—IL6—psoriasis	0.000454	0.00159	CbGpPWpGaD
Pentosan Polysulfate—Hyperhidrosis—Prednisolone—psoriasis	0.000454	0.000827	CcSEcCtD
Pentosan Polysulfate—Nausea—Hydroxyurea—psoriasis	0.000452	0.000824	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000452	0.000824	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—STAT3—psoriasis	0.000451	0.00158	CbGpPWpGaD
Pentosan Polysulfate—Pruritus—Mycophenolic acid—psoriasis	0.000451	0.000823	CcSEcCtD
Pentosan Polysulfate—Myalgia—Triamcinolone—psoriasis	0.00045	0.000821	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling by EGFR—IL6—psoriasis	0.00045	0.00157	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	0.000449	0.00157	CbGpPWpGaD
Pentosan Polysulfate—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000449	0.000818	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Cyclosporine—psoriasis	0.000448	0.000818	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by NGF—NFKBIA—psoriasis	0.000447	0.00156	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—HLA-E—psoriasis	0.000446	0.00156	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by EGFR in Cancer—IL6—psoriasis	0.000446	0.00156	CbGpPWpGaD
Pentosan Polysulfate—Depression—Methotrexate—psoriasis	0.000446	0.000813	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Betamethasone—psoriasis	0.000445	0.000812	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Dexamethasone—psoriasis	0.000445	0.000812	CcSEcCtD
Pentosan Polysulfate—FGF1—Downstream signal transduction—STAT3—psoriasis	0.000445	0.00156	CbGpPWpGaD
Pentosan Polysulfate—Discomfort—Triamcinolone—psoriasis	0.000445	0.000811	CcSEcCtD
Pentosan Polysulfate—FGF4—Adaptive Immune System—HLA-DRB1—psoriasis	0.000444	0.00155	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by PDGF—IL6—psoriasis	0.000444	0.00155	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—HLA-E—psoriasis	0.000444	0.00155	CbGpPWpGaD
Pentosan Polysulfate—FGF2—IGF1R signaling cascade—IL6—psoriasis	0.000443	0.00155	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Insulin receptor signalling cascade—IL6—psoriasis	0.000443	0.00155	CbGpPWpGaD
Pentosan Polysulfate—Hyperhidrosis—Hydrocortisone—psoriasis	0.000443	0.000808	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000443	0.000808	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling by NGF—STAT3—psoriasis	0.000443	0.00155	CbGpPWpGaD
Pentosan Polysulfate—Constipation—Cyclosporine—psoriasis	0.000441	0.000804	CcSEcCtD
Pentosan Polysulfate—FGF4—Innate Immune System—NFKBIA—psoriasis	0.00044	0.00154	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—psoriasis	0.000439	0.00153	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCL20—psoriasis	0.000438	0.00153	CbGpPWpGaD
Pentosan Polysulfate—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000437	0.000798	CcSEcCtD
Pentosan Polysulfate—Anorexia—Hydrocortisone—psoriasis	0.000437	0.000797	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Mycophenolic acid—psoriasis	0.000436	0.000795	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Methotrexate—psoriasis	0.000436	0.000794	CcSEcCtD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—JUN—psoriasis	0.000435	0.00152	CbGpPWpGaD
Pentosan Polysulfate—Conjunctivitis—Methotrexate—psoriasis	0.000434	0.000792	CcSEcCtD
Pentosan Polysulfate—Malaise—Betamethasone—psoriasis	0.000433	0.000789	CcSEcCtD
Pentosan Polysulfate—Malaise—Dexamethasone—psoriasis	0.000433	0.000789	CcSEcCtD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	0.000432	0.00151	CbGpPWpGaD
Pentosan Polysulfate—Oedema—Triamcinolone—psoriasis	0.000432	0.000787	CcSEcCtD
Pentosan Polysulfate—Constipation—Mycophenolate mofetil—psoriasis	0.00043	0.000785	CcSEcCtD
Pentosan Polysulfate—Infection—Triamcinolone—psoriasis	0.000429	0.000782	CcSEcCtD
Pentosan Polysulfate—Sweating—Methotrexate—psoriasis	0.000428	0.000781	CcSEcCtD
Pentosan Polysulfate—FGF4—Adaptive Immune System—ICAM1—psoriasis	0.000426	0.00149	CbGpPWpGaD
Pentosan Polysulfate—Haematuria—Methotrexate—psoriasis	0.000426	0.000777	CcSEcCtD
Pentosan Polysulfate—FGF2—Adaptive Immune System—HLA-E—psoriasis	0.000426	0.00149	CbGpPWpGaD
Pentosan Polysulfate—Feeling abnormal—Cyclosporine—psoriasis	0.000425	0.000775	CcSEcCtD
Pentosan Polysulfate—FGF1—B Cell Activation—NFKB1—psoriasis	0.000425	0.00149	CbGpPWpGaD
Pentosan Polysulfate—Insomnia—Prednisolone—psoriasis	0.000424	0.000774	CcSEcCtD
Pentosan Polysulfate—Alopecia—Prednisone—psoriasis	0.000424	0.000774	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling Pathways—TAGAP—psoriasis	0.000423	0.00148	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—NFKBIA—psoriasis	0.000423	0.00148	CbGpPWpGaD
Pentosan Polysulfate—Gastrointestinal pain—Cyclosporine—psoriasis	0.000422	0.000769	CcSEcCtD
Pentosan Polysulfate—Dizziness—Mycophenolic acid—psoriasis	0.000422	0.000769	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Methotrexate—psoriasis	0.000422	0.000769	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Prednisolone—psoriasis	0.000421	0.000768	CcSEcCtD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—NFKB1—psoriasis	0.000419	0.00146	CbGpPWpGaD
Pentosan Polysulfate—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000418	0.000762	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Triamcinolone—psoriasis	0.000417	0.000761	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000415	0.000756	CcSEcCtD
Pentosan Polysulfate—Insomnia—Hydrocortisone—psoriasis	0.000415	0.000756	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by FGFR in disease—STAT3—psoriasis	0.000413	0.00144	CbGpPWpGaD
Pentosan Polysulfate—Paraesthesia—Hydrocortisone—psoriasis	0.000412	0.000751	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000411	0.00075	CcSEcCtD
Pentosan Polysulfate—Urticaria—Cyclosporine—psoriasis	0.00041	0.000747	CcSEcCtD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	0.000409	0.00143	CbGpPWpGaD
Pentosan Polysulfate—Myalgia—Betamethasone—psoriasis	0.000409	0.000745	CcSEcCtD
Pentosan Polysulfate—Myalgia—Dexamethasone—psoriasis	0.000409	0.000745	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Cyclosporine—psoriasis	0.000408	0.000743	CcSEcCtD
Pentosan Polysulfate—FGF1—Innate Immune System—SOCS1—psoriasis	0.000406	0.00142	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signal transduction—STAT3—psoriasis	0.000406	0.00142	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Mycophenolic acid—psoriasis	0.000405	0.000739	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by Insulin receptor—IL6—psoriasis	0.000404	0.00141	CbGpPWpGaD
Pentosan Polysulfate—Discomfort—Betamethasone—psoriasis	0.000404	0.000736	CcSEcCtD
Pentosan Polysulfate—Discomfort—Dexamethasone—psoriasis	0.000404	0.000736	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Hydrocortisone—psoriasis	0.000403	0.000736	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by PDGF—STAT3—psoriasis	0.000403	0.00141	CbGpPWpGaD
Pentosan Polysulfate—FGF4—NGF signalling via TRKA from the plasma membrane—IL6—psoriasis	0.000402	0.00141	CbGpPWpGaD
Pentosan Polysulfate—Rash—Mycophenolic acid—psoriasis	0.000402	0.000733	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Mycophenolic acid—psoriasis	0.000402	0.000732	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by NGF—TYK2—psoriasis	0.000401	0.0014	CbGpPWpGaD
Pentosan Polysulfate—Urticaria—Mycophenolate mofetil—psoriasis	0.0004	0.000729	CcSEcCtD
Pentosan Polysulfate—Headache—Mycophenolic acid—psoriasis	0.000399	0.000728	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Hydrocortisone—psoriasis	0.000398	0.000727	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Methotrexate—psoriasis	0.000398	0.000726	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000398	0.000725	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—ITGAL—psoriasis	0.000397	0.00139	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	0.000394	0.00138	CbGpPWpGaD
Pentosan Polysulfate—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000393	0.000717	CcSEcCtD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	0.000392	0.00137	CbGpPWpGaD
Pentosan Polysulfate—Oedema—Dexamethasone—psoriasis	0.000392	0.000714	CcSEcCtD
Pentosan Polysulfate—Oedema—Betamethasone—psoriasis	0.000392	0.000714	CcSEcCtD
Pentosan Polysulfate—Insomnia—Triamcinolone—psoriasis	0.00039	0.000712	CcSEcCtD
Pentosan Polysulfate—FGF1—Adaptive Immune System—SOCS1—psoriasis	0.00039	0.00136	CbGpPWpGaD
Pentosan Polysulfate—Infection—Betamethasone—psoriasis	0.000389	0.000709	CcSEcCtD
Pentosan Polysulfate—Infection—Dexamethasone—psoriasis	0.000389	0.000709	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Prednisone—psoriasis	0.000388	0.000707	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Triamcinolone—psoriasis	0.000388	0.000707	CcSEcCtD
Pentosan Polysulfate—FGF2—B Cell Activation—NFKB1—psoriasis	0.000387	0.00135	CbGpPWpGaD
Pentosan Polysulfate—Feeling abnormal—Prednisolone—psoriasis	0.000387	0.000705	CcSEcCtD
Pentosan Polysulfate—Anaemia—Prednisone—psoriasis	0.000386	0.000704	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Triamcinolone—psoriasis	0.000385	0.000702	CcSEcCtD
Pentosan Polysulfate—Agitation—Prednisone—psoriasis	0.000384	0.0007	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Betamethasone—psoriasis	0.000383	0.000699	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Dexamethasone—psoriasis	0.000383	0.000699	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Cyclosporine—psoriasis	0.00038	0.000693	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Triamcinolone—psoriasis	0.00038	0.000693	CcSEcCtD
Pentosan Polysulfate—Nausea—Mycophenolic acid—psoriasis	0.000379	0.000691	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Betamethasone—psoriasis	0.000379	0.00069	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Dexamethasone—psoriasis	0.000379	0.00069	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Hydrocortisone—psoriasis	0.000378	0.000689	CcSEcCtD
Pentosan Polysulfate—Malaise—Prednisone—psoriasis	0.000377	0.000687	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—STAT3—psoriasis	0.000376	0.00132	CbGpPWpGaD
Pentosan Polysulfate—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000375	0.000683	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Methotrexate—psoriasis	0.000374	0.000682	CcSEcCtD
Pentosan Polysulfate—Anorexia—Dexamethasone—psoriasis	0.000373	0.000681	CcSEcCtD
Pentosan Polysulfate—Anorexia—Betamethasone—psoriasis	0.000373	0.000681	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—SOCS1—psoriasis	0.000373	0.0013	CbGpPWpGaD
Pentosan Polysulfate—Urticaria—Prednisolone—psoriasis	0.000373	0.00068	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—REL—psoriasis	0.000371	0.0013	CbGpPWpGaD
Pentosan Polysulfate—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000371	0.000676	CcSEcCtD
Pentosan Polysulfate—FGF2—Innate Immune System—SOCS1—psoriasis	0.000371	0.0013	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by Insulin receptor—IL6—psoriasis	0.000368	0.00129	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—STAT3—psoriasis	0.000368	0.00129	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—TYK2—psoriasis	0.000366	0.00128	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—STAT3—psoriasis	0.000365	0.00128	CbGpPWpGaD
Pentosan Polysulfate—Pruritus—Cyclosporine—psoriasis	0.000365	0.000665	CcSEcCtD
Pentosan Polysulfate—Urticaria—Hydrocortisone—psoriasis	0.000364	0.000664	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Hydrocortisone—psoriasis	0.000362	0.000661	CcSEcCtD
Pentosan Polysulfate—FGF2—Immune System—ITGAL—psoriasis	0.000362	0.00127	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—TYK2—psoriasis	0.000361	0.00126	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IFIH1—psoriasis	0.00036	0.00126	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	0.000357	0.00125	CbGpPWpGaD
Pentosan Polysulfate—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000357	0.000651	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000357	0.000651	CcSEcCtD
Pentosan Polysulfate—Pruritus—Mycophenolate mofetil—psoriasis	0.000356	0.000649	CcSEcCtD
Pentosan Polysulfate—FGF2—Adaptive Immune System—SOCS1—psoriasis	0.000356	0.00124	CbGpPWpGaD
Pentosan Polysulfate—Myalgia—Prednisone—psoriasis	0.000356	0.000649	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Prednisone—psoriasis	0.000356	0.000649	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Triamcinolone—psoriasis	0.000356	0.000649	CcSEcCtD
Pentosan Polysulfate—Alopecia—Methotrexate—psoriasis	0.000355	0.000646	CcSEcCtD
Pentosan Polysulfate—Insomnia—Dexamethasone—psoriasis	0.000354	0.000646	CcSEcCtD
Pentosan Polysulfate—Insomnia—Betamethasone—psoriasis	0.000354	0.000646	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Cyclosporine—psoriasis	0.000353	0.000644	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Dexamethasone—psoriasis	0.000352	0.000641	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Betamethasone—psoriasis	0.000352	0.000641	CcSEcCtD
Pentosan Polysulfate—Discomfort—Prednisone—psoriasis	0.000352	0.000641	CcSEcCtD
Pentosan Polysulfate—FGF1—Innate Immune System—HLA-B—psoriasis	0.000347	0.00121	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—CD8A—psoriasis	0.000346	0.00121	CbGpPWpGaD
Pentosan Polysulfate—Hypersensitivity—Prednisolone—psoriasis	0.000346	0.000631	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by SCF-KIT—IL6—psoriasis	0.000346	0.00121	CbGpPWpGaD
Pentosan Polysulfate—Dyspepsia—Betamethasone—psoriasis	0.000345	0.000629	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Dexamethasone—psoriasis	0.000345	0.000629	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000344	0.000628	CcSEcCtD
Pentosan Polysulfate—Urticaria—Triamcinolone—psoriasis	0.000343	0.000625	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—HLA-C—psoriasis	0.000341	0.00119	CbGpPWpGaD
Pentosan Polysulfate—Dizziness—Cyclosporine—psoriasis	0.000341	0.000622	CcSEcCtD
Pentosan Polysulfate—Oedema—Prednisone—psoriasis	0.000341	0.000622	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Dexamethasone—psoriasis	0.00034	0.000621	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Betamethasone—psoriasis	0.00034	0.000621	CcSEcCtD
Pentosan Polysulfate—Infection—Prednisone—psoriasis	0.000339	0.000618	CcSEcCtD
Pentosan Polysulfate—FGF2—Immune System—REL—psoriasis	0.000338	0.00118	CbGpPWpGaD
Pentosan Polysulfate—Hypersensitivity—Hydrocortisone—psoriasis	0.000338	0.000616	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—TNFAIP3—psoriasis	0.000337	0.00118	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	0.000336	0.00118	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—STAT3—psoriasis	0.000333	0.00117	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—HLA-B—psoriasis	0.000333	0.00116	CbGpPWpGaD
Pentosan Polysulfate—Dizziness—Mycophenolate mofetil—psoriasis	0.000333	0.000607	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—CD8A—psoriasis	0.000331	0.00116	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling of activated FGFR—IL6—psoriasis	0.000331	0.00116	CbGpPWpGaD
Pentosan Polysulfate—Hyperhidrosis—Prednisone—psoriasis	0.00033	0.000601	CcSEcCtD
Pentosan Polysulfate—FGF2—Immune System—IFIH1—psoriasis	0.000328	0.00115	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Cyclosporine—psoriasis	0.000328	0.000598	CcSEcCtD
Pentosan Polysulfate—FGF4—Innate Immune System—CD4—psoriasis	0.000326	0.00114	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB4—IL6—psoriasis	0.000325	0.00114	CbGpPWpGaD
Pentosan Polysulfate—Rash—Cyclosporine—psoriasis	0.000325	0.000593	CcSEcCtD
Pentosan Polysulfate—Anorexia—Prednisone—psoriasis	0.000325	0.000593	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Cyclosporine—psoriasis	0.000325	0.000592	CcSEcCtD
Pentosan Polysulfate—Pruritus—Hydrocortisone—psoriasis	0.000324	0.000591	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Methotrexate—psoriasis	0.000324	0.000591	CcSEcCtD
Pentosan Polysulfate—Headache—Cyclosporine—psoriasis	0.000323	0.000589	CcSEcCtD
Pentosan Polysulfate—Anaemia—Methotrexate—psoriasis	0.000323	0.000589	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Betamethasone—psoriasis	0.000323	0.000588	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Dexamethasone—psoriasis	0.000323	0.000588	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Betamethasone—psoriasis	0.00032	0.000584	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Dexamethasone—psoriasis	0.00032	0.000584	CcSEcCtD
Pentosan Polysulfate—Vomiting—Mycophenolate mofetil—psoriasis	0.00032	0.000583	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—HLA-B—psoriasis	0.000318	0.00111	CbGpPWpGaD
Pentosan Polysulfate—Hypersensitivity—Triamcinolone—psoriasis	0.000318	0.00058	CcSEcCtD
Pentosan Polysulfate—Rash—Mycophenolate mofetil—psoriasis	0.000317	0.000578	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Mycophenolate mofetil—psoriasis	0.000317	0.000578	CcSEcCtD
Pentosan Polysulfate—FGF2—Innate Immune System—HLA-B—psoriasis	0.000316	0.00111	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CD8A—psoriasis	0.000316	0.0011	CbGpPWpGaD
Pentosan Polysulfate—Headache—Mycophenolate mofetil—psoriasis	0.000315	0.000575	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—IL6—psoriasis	0.000315	0.0011	CbGpPWpGaD
Pentosan Polysulfate—Malaise—Methotrexate—psoriasis	0.000315	0.000574	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Hydrocortisone—psoriasis	0.000314	0.000572	CcSEcCtD
Pentosan Polysulfate—FGF4—Adaptive Immune System—CD4—psoriasis	0.000313	0.0011	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—NFKB1—psoriasis	0.000313	0.00109	CbGpPWpGaD
Pentosan Polysulfate—Leukopenia—Methotrexate—psoriasis	0.000313	0.00057	CcSEcCtD
Pentosan Polysulfate—FGF2—Immune System—HLA-C—psoriasis	0.000311	0.00109	CbGpPWpGaD
Pentosan Polysulfate—Urticaria—Dexamethasone—psoriasis	0.000311	0.000567	CcSEcCtD
Pentosan Polysulfate—Urticaria—Betamethasone—psoriasis	0.000311	0.000567	CcSEcCtD
Pentosan Polysulfate—FGF1—Downstream signal transduction—IL6—psoriasis	0.000311	0.00109	CbGpPWpGaD
Pentosan Polysulfate—Musculoskeletal discomfort—Prednisone—psoriasis	0.000311	0.000567	CcSEcCtD
Pentosan Polysulfate—Dizziness—Prednisolone—psoriasis	0.00031	0.000566	CcSEcCtD
Pentosan Polysulfate—FGF2—Developmental Biology—LEP—psoriasis	0.00031	0.00108	CbGpPWpGaD
Pentosan Polysulfate—Abdominal pain—Betamethasone—psoriasis	0.00031	0.000565	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Dexamethasone—psoriasis	0.00031	0.000565	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by FGFR—IL6—psoriasis	0.000309	0.00108	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by NGF—IL6—psoriasis	0.000309	0.00108	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—HLA-A—psoriasis	0.000308	0.00108	CbGpPWpGaD
Pentosan Polysulfate—Insomnia—Prednisone—psoriasis	0.000308	0.000562	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by ERBB2—IL6—psoriasis	0.000308	0.00108	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—TNFAIP3—psoriasis	0.000308	0.00108	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—CRP—psoriasis	0.000306	0.00107	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Cyclosporine—psoriasis	0.000306	0.000559	CcSEcCtD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	0.000306	0.00107	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 signaling—IL6—psoriasis	0.000306	0.00107	CbGpPWpGaD
Pentosan Polysulfate—Paraesthesia—Prednisone—psoriasis	0.000306	0.000558	CcSEcCtD
Pentosan Polysulfate—Pruritus—Triamcinolone—psoriasis	0.000305	0.000557	CcSEcCtD
Pentosan Polysulfate—FGF2—Adaptive Immune System—HLA-B—psoriasis	0.000304	0.00106	CbGpPWpGaD
Pentosan Polysulfate—Dizziness—Hydrocortisone—psoriasis	0.000303	0.000553	CcSEcCtD
Pentosan Polysulfate—FGF2—Downstream signaling of activated FGFR—IL6—psoriasis	0.000302	0.00105	CbGpPWpGaD
Pentosan Polysulfate—Dyspepsia—Prednisone—psoriasis	0.0003	0.000547	CcSEcCtD
Pentosan Polysulfate—Nausea—Mycophenolate mofetil—psoriasis	0.000299	0.000545	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Methotrexate—psoriasis	0.000297	0.000542	CcSEcCtD
Pentosan Polysulfate—Myalgia—Methotrexate—psoriasis	0.000297	0.000542	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by ERBB4—IL6—psoriasis	0.000297	0.00104	CbGpPWpGaD
Pentosan Polysulfate—Decreased appetite—Prednisone—psoriasis	0.000296	0.000541	CcSEcCtD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	0.000296	0.00104	CbGpPWpGaD
Pentosan Polysulfate—Rash—Prednisolone—psoriasis	0.000296	0.00054	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Prednisolone—psoriasis	0.000296	0.000539	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—HLA-A—psoriasis	0.000295	0.00103	CbGpPWpGaD
Pentosan Polysulfate—Headache—Prednisolone—psoriasis	0.000294	0.000536	CcSEcCtD
Pentosan Polysulfate—Discomfort—Methotrexate—psoriasis	0.000294	0.000536	CcSEcCtD
Pentosan Polysulfate—FGF4—Innate Immune System—JUN—psoriasis	0.000292	0.00102	CbGpPWpGaD
Pentosan Polysulfate—Constipation—Prednisone—psoriasis	0.000292	0.000532	CcSEcCtD
Pentosan Polysulfate—Vomiting—Hydrocortisone—psoriasis	0.000291	0.000531	CcSEcCtD
Pentosan Polysulfate—Rash—Hydrocortisone—psoriasis	0.000289	0.000527	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Hydrocortisone—psoriasis	0.000289	0.000527	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by FGFR in disease—IL6—psoriasis	0.000288	0.00101	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Fc epsilon receptor (FCERI) signaling—IL6—psoriasis	0.000288	0.00101	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 interactions—IL6—psoriasis	0.000288	0.00101	CbGpPWpGaD
Pentosan Polysulfate—Headache—Hydrocortisone—psoriasis	0.000287	0.000524	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by EGFR—IL6—psoriasis	0.000286	0.000999	CbGpPWpGaD
Pentosan Polysulfate—Dizziness—Triamcinolone—psoriasis	0.000285	0.00052	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by NGF—NFKB1—psoriasis	0.000285	0.000997	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signal transduction—IL6—psoriasis	0.000283	0.000991	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—HLA-E—psoriasis	0.000283	0.000991	CbGpPWpGaD
Pentosan Polysulfate—Infection—Methotrexate—psoriasis	0.000283	0.000516	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—IL6—psoriasis	0.000283	0.00099	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR—IL6—psoriasis	0.000282	0.000986	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—HLA-DRB1—psoriasis	0.000282	0.000986	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by PDGF—IL6—psoriasis	0.000282	0.000986	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—HLA-A—psoriasis	0.000281	0.000984	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CRP—psoriasis	0.000281	0.000984	CbGpPWpGaD
Pentosan Polysulfate—Feeling abnormal—Prednisone—psoriasis	0.000281	0.000512	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by NGF—STAT3—psoriasis	0.000281	0.000983	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—NFKB1—psoriasis	0.000281	0.000983	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—IL6—psoriasis	0.000281	0.000982	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—CRP—psoriasis	0.000279	0.000977	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—NFKBIA—psoriasis	0.000279	0.000977	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 signaling—IL6—psoriasis	0.000279	0.000977	CbGpPWpGaD
Pentosan Polysulfate—Thrombocytopenia—Methotrexate—psoriasis	0.000279	0.000509	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Prednisone—psoriasis	0.000279	0.000509	CcSEcCtD
Pentosan Polysulfate—Nausea—Prednisolone—psoriasis	0.000279	0.000508	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCL20—psoriasis	0.000278	0.000972	CbGpPWpGaD
Pentosan Polysulfate—Pruritus—Betamethasone—psoriasis	0.000277	0.000505	CcSEcCtD
Pentosan Polysulfate—Pruritus—Dexamethasone—psoriasis	0.000277	0.000505	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Methotrexate—psoriasis	0.000276	0.000502	CcSEcCtD
Pentosan Polysulfate—Vomiting—Triamcinolone—psoriasis	0.000274	0.0005	CcSEcCtD
Pentosan Polysulfate—Nausea—Hydrocortisone—psoriasis	0.000272	0.000496	CcSEcCtD
Pentosan Polysulfate—FGF4—Disease—HLA-A—psoriasis	0.000272	0.000952	CbGpPWpGaD
Pentosan Polysulfate—Rash—Triamcinolone—psoriasis	0.000272	0.000496	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Triamcinolone—psoriasis	0.000272	0.000496	CcSEcCtD
Pentosan Polysulfate—Anorexia—Methotrexate—psoriasis	0.000272	0.000495	CcSEcCtD
Pentosan Polysulfate—Urticaria—Prednisone—psoriasis	0.000271	0.000494	CcSEcCtD
Pentosan Polysulfate—FGF1—Adaptive Immune System—ICAM1—psoriasis	0.00027	0.000946	CbGpPWpGaD
Pentosan Polysulfate—Headache—Triamcinolone—psoriasis	0.00027	0.000493	CcSEcCtD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	0.00027	0.000945	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—NFKB1—psoriasis	0.00027	0.000944	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—PPARG—psoriasis	0.00027	0.000943	CbGpPWpGaD
Pentosan Polysulfate—Abdominal pain—Prednisone—psoriasis	0.00027	0.000492	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—HLA-DRB1—psoriasis	0.000269	0.000942	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—NFKBIA—psoriasis	0.000268	0.000939	CbGpPWpGaD
Pentosan Polysulfate—Diarrhoea—Betamethasone—psoriasis	0.000268	0.000489	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Dexamethasone—psoriasis	0.000268	0.000489	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—IL6—psoriasis	0.000263	0.000919	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—IL6—psoriasis	0.000263	0.000919	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—IL6—psoriasis	0.000263	0.000919	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—IL6—psoriasis	0.00026	0.000911	CbGpPWpGaD
Pentosan Polysulfate—Musculoskeletal discomfort—Methotrexate—psoriasis	0.00026	0.000474	CcSEcCtD
Pentosan Polysulfate—Dizziness—Betamethasone—psoriasis	0.000259	0.000472	CcSEcCtD
Pentosan Polysulfate—Dizziness—Dexamethasone—psoriasis	0.000259	0.000472	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—ICAM1—psoriasis	0.000258	0.000904	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—HLA-E—psoriasis	0.000258	0.000904	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—IL6—psoriasis	0.000258	0.000903	CbGpPWpGaD
Pentosan Polysulfate—Insomnia—Methotrexate—psoriasis	0.000258	0.00047	CcSEcCtD
Pentosan Polysulfate—FGF2—Adaptive Immune System—HLA-DRB1—psoriasis	0.000257	0.000899	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—IL6—psoriasis	0.000257	0.000899	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—NFKBIA—psoriasis	0.000256	0.000897	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Triamcinolone—psoriasis	0.000256	0.000467	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by NGF—STAT3—psoriasis	0.000256	0.000896	CbGpPWpGaD
Pentosan Polysulfate—Paraesthesia—Methotrexate—psoriasis	0.000256	0.000467	CcSEcCtD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—IL6—psoriasis	0.000255	0.000893	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—NFKBIA—psoriasis	0.000255	0.000891	CbGpPWpGaD
Pentosan Polysulfate—Dyspnoea—Methotrexate—psoriasis	0.000254	0.000463	CcSEcCtD
Pentosan Polysulfate—FGF4—Disease—APOE—psoriasis	0.000254	0.000889	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCL20—psoriasis	0.000253	0.000886	CbGpPWpGaD
Pentosan Polysulfate—Hypersensitivity—Prednisone—psoriasis	0.000251	0.000458	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Methotrexate—psoriasis	0.000251	0.000458	CcSEcCtD
Pentosan Polysulfate—Vomiting—Betamethasone—psoriasis	0.000249	0.000454	CcSEcCtD
Pentosan Polysulfate—Vomiting—Dexamethasone—psoriasis	0.000249	0.000454	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Methotrexate—psoriasis	0.000248	0.000452	CcSEcCtD
Pentosan Polysulfate—Rash—Dexamethasone—psoriasis	0.000247	0.00045	CcSEcCtD
Pentosan Polysulfate—Rash—Betamethasone—psoriasis	0.000247	0.00045	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Betamethasone—psoriasis	0.000247	0.00045	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Dexamethasone—psoriasis	0.000247	0.00045	CcSEcCtD
Pentosan Polysulfate—FGF2—Adaptive Immune System—ICAM1—psoriasis	0.000247	0.000863	CbGpPWpGaD
Pentosan Polysulfate—Headache—Dexamethasone—psoriasis	0.000245	0.000447	CcSEcCtD
Pentosan Polysulfate—Headache—Betamethasone—psoriasis	0.000245	0.000447	CcSEcCtD
Pentosan Polysulfate—FGF2—Adaptive Immune System—NFKBIA—psoriasis	0.000245	0.000856	CbGpPWpGaD
Pentosan Polysulfate—Pruritus—Prednisone—psoriasis	0.000241	0.00044	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling Pathways—SOCS1—psoriasis	0.000241	0.000843	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—NOS2—psoriasis	0.000237	0.000828	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—SOCS1—psoriasis	0.000237	0.000828	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—TYK2—psoriasis	0.000236	0.000827	CbGpPWpGaD
Pentosan Polysulfate—Feeling abnormal—Methotrexate—psoriasis	0.000235	0.000428	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Prednisone—psoriasis	0.000233	0.000426	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Methotrexate—psoriasis	0.000233	0.000425	CcSEcCtD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—IL6—psoriasis	0.000233	0.000814	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Dexamethasone—psoriasis	0.000233	0.000424	CcSEcCtD
Pentosan Polysulfate—Nausea—Betamethasone—psoriasis	0.000233	0.000424	CcSEcCtD
Pentosan Polysulfate—FGF1—Innate Immune System—TYK2—psoriasis	0.000229	0.000801	CbGpPWpGaD
Pentosan Polysulfate—Urticaria—Methotrexate—psoriasis	0.000226	0.000413	CcSEcCtD
Pentosan Polysulfate—Dizziness—Prednisone—psoriasis	0.000226	0.000411	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Methotrexate—psoriasis	0.000225	0.000411	CcSEcCtD
Pentosan Polysulfate—Vomiting—Prednisone—psoriasis	0.000217	0.000395	CcSEcCtD
Pentosan Polysulfate—FGF2—Immune System—SOCS1—psoriasis	0.000216	0.000755	CbGpPWpGaD
Pentosan Polysulfate—Rash—Prednisone—psoriasis	0.000215	0.000392	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Prednisone—psoriasis	0.000215	0.000392	CcSEcCtD
Pentosan Polysulfate—Headache—Prednisone—psoriasis	0.000214	0.00039	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—TYK2—psoriasis	0.00021	0.000735	CbGpPWpGaD
Pentosan Polysulfate—Hypersensitivity—Methotrexate—psoriasis	0.00021	0.000383	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—CD8A—psoriasis	0.00021	0.000734	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—TYK2—psoriasis	0.000209	0.00073	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—CD4—psoriasis	0.000207	0.000724	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Prednisone—psoriasis	0.000203	0.000369	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—HLA-B—psoriasis	0.000202	0.000706	CbGpPWpGaD
Pentosan Polysulfate—Pruritus—Methotrexate—psoriasis	0.000202	0.000368	CcSEcCtD
Pentosan Polysulfate—FGF1—Adaptive Immune System—CD4—psoriasis	0.000199	0.000695	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IFNG—psoriasis	0.000197	0.000688	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—IL6—psoriasis	0.000196	0.000687	CbGpPWpGaD
Pentosan Polysulfate—Diarrhoea—Methotrexate—psoriasis	0.000195	0.000356	CcSEcCtD
Pentosan Polysulfate—FGF4—Disease—TYK2—psoriasis	0.000194	0.000678	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CD8A—psoriasis	0.000191	0.00067	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CD4—psoriasis	0.00019	0.000664	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—CD4—psoriasis	0.000189	0.00066	CbGpPWpGaD
Pentosan Polysulfate—Dizziness—Methotrexate—psoriasis	0.000188	0.000344	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—HLA-A—psoriasis	0.000187	0.000654	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—JUN—psoriasis	0.000185	0.000648	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—NFKB1—psoriasis	0.000184	0.000644	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—HLA-B—psoriasis	0.000184	0.000644	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CD4—psoriasis	0.000181	0.000634	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Methotrexate—psoriasis	0.000181	0.00033	CcSEcCtD
Pentosan Polysulfate—Rash—Methotrexate—psoriasis	0.00018	0.000328	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Methotrexate—psoriasis	0.00018	0.000327	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by NGF—IL6—psoriasis	0.000179	0.000626	CbGpPWpGaD
Pentosan Polysulfate—Headache—Methotrexate—psoriasis	0.000179	0.000326	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—CRP—psoriasis	0.000178	0.000624	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—NFKB1—psoriasis	0.000178	0.000624	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—LEP—psoriasis	0.000178	0.000622	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—APOE—psoriasis	0.000178	0.000622	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—IL6—psoriasis	0.000176	0.000617	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—CD4—psoriasis	0.000175	0.000613	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—HLA-A—psoriasis	0.000173	0.000604	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—NFKB1—psoriasis	0.000171	0.000599	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—HLA-DRB1—psoriasis	0.000171	0.000598	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—HLA-A—psoriasis	0.000171	0.000597	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—JUN—psoriasis	0.00017	0.000595	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Methotrexate—psoriasis	0.000169	0.000309	CcSEcCtD
Pentosan Polysulfate—FGF2—Innate Immune System—JUN—psoriasis	0.000169	0.000591	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—VEGFA—psoriasis	0.000167	0.000585	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NFKBIA—psoriasis	0.000166	0.00058	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—STAT3—psoriasis	0.000165	0.000579	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—ICAM1—psoriasis	0.000164	0.000574	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—NFKB1—psoriasis	0.000164	0.000572	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—NFKBIA—psoriasis	0.000163	0.000569	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CRP—psoriasis	0.000163	0.000569	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—NFKB1—psoriasis	0.000163	0.000569	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—APOE—psoriasis	0.000161	0.000564	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—HLA-A—psoriasis	0.000158	0.000551	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—NFKB1—psoriasis	0.000156	0.000546	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—HLA-DRB1—psoriasis	0.000156	0.000545	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SOCS1—psoriasis	0.000153	0.000535	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NOS2—psoriasis	0.00015	0.000526	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—ICAM1—psoriasis	0.00015	0.000523	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—NFKBIA—psoriasis	0.000148	0.000519	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—STAT3—psoriasis	0.000147	0.000514	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—APOE—psoriasis	0.000147	0.000514	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—TNF—psoriasis	0.000143	0.000501	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SOCS1—psoriasis	0.00014	0.000488	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NOS2—psoriasis	0.000137	0.000479	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TYK2—psoriasis	0.000136	0.000475	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—STAT3—psoriasis	0.000136	0.000475	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—TYK2—psoriasis	0.000133	0.000466	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IFNG—psoriasis	0.000125	0.000437	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—TYK2—psoriasis	0.000123	0.000431	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—TYK2—psoriasis	0.000122	0.000425	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CD4—psoriasis	0.000121	0.000422	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CXCL8—psoriasis	0.000118	0.000414	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—IL6—psoriasis	0.000116	0.000404	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IFNG—psoriasis	0.000114	0.000398	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—APOE—psoriasis	0.000113	0.000395	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—LEP—psoriasis	0.000113	0.000395	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—TYK2—psoriasis	0.000112	0.000393	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—IL6—psoriasis	0.000112	0.000392	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CD4—psoriasis	0.000111	0.000389	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CD4—psoriasis	0.00011	0.000385	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—JUN—psoriasis	0.00011	0.000384	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—JUN—psoriasis	0.000108	0.000377	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NFKB1—psoriasis	0.000106	0.00037	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NFKBIA—psoriasis	0.000105	0.000368	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—NFKB1—psoriasis	0.000104	0.000363	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—LEP—psoriasis	0.000103	0.00036	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—APOE—psoriasis	0.000103	0.00036	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IL6—psoriasis	0.000103	0.000359	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—IL6—psoriasis	0.000102	0.000357	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CD4—psoriasis	0.000102	0.000355	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—JUN—psoriasis	9.84e-05	0.000344	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—VEGFA—psoriasis	9.6e-05	0.000336	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NFKBIA—psoriasis	9.6e-05	0.000336	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—STAT3—psoriasis	9.51e-05	0.000333	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—IL6—psoriasis	9.48e-05	0.000332	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—NFKB1—psoriasis	9.47e-05	0.000331	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—STAT3—psoriasis	9.33e-05	0.000327	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TYK2—psoriasis	8.62e-05	0.000301	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—STAT3—psoriasis	8.62e-05	0.000301	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—STAT3—psoriasis	8.51e-05	0.000298	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TYK2—psoriasis	7.86e-05	0.000275	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—STAT3—psoriasis	7.86e-05	0.000275	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CXCL8—psoriasis	7.5e-05	0.000262	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TP53—psoriasis	7.26e-05	0.000254	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—JUN—psoriasis	6.98e-05	0.000244	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CXCL8—psoriasis	6.84e-05	0.000239	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NFKB1—psoriasis	6.72e-05	0.000235	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL6—psoriasis	6.64e-05	0.000232	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL6—psoriasis	6.52e-05	0.000228	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—JUN—psoriasis	6.36e-05	0.000223	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NFKB1—psoriasis	6.12e-05	0.000214	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—VEGFA—psoriasis	6.1e-05	0.000213	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—STAT3—psoriasis	6.04e-05	0.000211	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—IL6—psoriasis	6.02e-05	0.000211	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL6—psoriasis	5.95e-05	0.000208	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—VEGFA—psoriasis	5.56e-05	0.000194	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—STAT3—psoriasis	5.5e-05	0.000193	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—IL6—psoriasis	5.49e-05	0.000192	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TP53—psoriasis	4.61e-05	0.000161	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL6—psoriasis	4.22e-05	0.000147	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TP53—psoriasis	4.2e-05	0.000147	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL6—psoriasis	3.84e-05	0.000134	CbGpPWpGaD
